PANACEA: An Internet of Bio-NanoThings Application for Early Detection and Mitigation of Infectious Diseases - Genetically Engineered Cells ITU-IEEE 6G
COVID-19 | “In 2002, the University of North Carolina, Chapel Hill Patented An Infectious Replication Defective Clone of Coronavirus. Infectious Replication Defective Means a Weapon.” - Dr. Martin (Read Patents In Description)
COVID-19 | “In 2002, the University of North Carolina, Chapel Hill Patented An Infectious Replication Defective Clone of Coronavirus. Infectious Replication Defective Means a Weapon.” - Dr. Martin (Read Patents In Description) 7 TRUTH BOMBS